OOIR: Observatory of International Research

Papers

(The median citation count of Prostate International is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer	43
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship	31
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification	23
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization	23
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study	17
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy	16
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer	16
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study	15
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey	15
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer	14
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis	13
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study	13
Association between preoperative prostate-specific antigen levels and mortality in high- and intermediate-grade prostate cancer patients who received radical prostatectomy: Findings from the SEER data	12
Rebiopsy rate after transperineal or transrectal prostate biopsy	12
Changing trends in robot-assisted radical prostatectomy: Inverse stage migration—A retrospective analysis	12
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign	12
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis	11
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre	11
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients	10
Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data	10
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures	9
Impact of inflammatory bowel disease on radical prostatectomy outcomes and costs of care	9
The prevalence of dyslipidemia in patients with prostate cancer	9
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer	8
Assessing the influence of prostate tissue traits on Gallium-68 prostate-specific membrane-antigen positron-emission tomography/computed tomography: predictive factors for image positivity and locoreg	8

The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension	8
High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group	8
Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg	8
Evaluation of the efficiency of transurethral enucleation with bipolar energy according to prostate volume for patients with benign prostate hyperplasia	8
Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and c	8
Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis	8
Comparing the efficacy of tadalafil and tamsulosin for managing erectile dysfunction and lower urinary tract symptoms in prostate brachytherapy patients: a prospective study	8
Time to castrate the cost? the rising expense of chemical castration for the management of prostate cancer	8
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer	8
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia	8
A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation	7
Irreversible electroporation for prostate cancer using PSMA PET-CT	7
Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: Short-term follow-up results	7
Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)	7
Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study	7
RNA-seq profile of African American men with a clinically localized prostate cancer	6
A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant prostate cancer in targeted biopsies: lesion density	6
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study	6
Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging	6
Single-port and multiport robot-assisted radical prostatectomy: A meta-analysis	6
Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system	6
Preoperative prostatic artery embolization before transurethral resection of the prostate for prostate glands larger than 80 mL: the first randomized controlled trial	6
Prostate diseases and microbiome in the prostate, gut, and urine	6
Application of robotics in the treatment of benign prostatic hyperplasia: a narrative review	6
Does music from noise-canceling headphones have a beneficial effect on men undergoing transrectal ultrasound-guided prostate biopsy?	6
Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy	6
Corrigendum to “Screening and validation of novel serum panel of microRNA in stratification of prostate cancer” [Prostate Int 11 (2023) 150–158]	5
Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description	5
Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates	5
Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: A study at a high-volume center in Korea	5
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study	5
Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy	5
Exploring the potential of ex-vivo 7-T magnetic resonance imaging on patients with clinically significant prostate cancer: visibility and size perspective	5
Screening and validation of novel serum panel of microRNA in stratification of prostate cancer	5
Comparisons of three scoring systems based on biparametric magnetic resonance imaging for prediction of clinically significant prostate cancer	5
Artificial intelligence–driven digital pathology in urological cancers: current trends and future directions	5
Robotic-assisted simple prostatectomy versus holmium laser enucleation of the prostate for large benign prostatic hyperplasia: A single-center preliminary study in Korea	5
Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study	5
Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score–matched analysis	5
Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men	5
Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer	4
Propensity score matched analysis of functional outcome in five thousand cases of robot-assisted radical prostatectomy versus high-intensity focused ultrasound	4
Detection of anterior prostate cancer using a magnetic resonance imaging-transrectal ultrasound fusion biopsy in cases with initial biopsy and history of systematic biopsies	4
Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes	4
How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?	4
Reviving intimacy: Penile rehabilitation strategies for men after prostate cancer treatment	4
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer	4
The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A prop	4
Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials	4
Pelvic lymph node management in prostate cancer: a narrative review	4

Prognosis after radical prostatectomy in men older than 75 years: long-term results from a single tertiary center	4
Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center	4
Predictors of readmission and impact of same-day discharge in holmium laser enucleation of the prostate	4
Effects of bladder neck sparing on continence outcomes of robotic-assisted radical prostatectomy: a systemic review and metaanalysis	4
The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement	3
Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets	3
Cardiovascular risks of Asian patients on androgen-receptor-targeted agents for prostate cancer: a systematic review and meta-analysis	3
A novel anterior approach that involves Retzius space development between the umbilical ligaments is associated with a lower incidence of postoperative inguinal hernia in robotic radical prostatectomy	3
Dr. Answer AI for prostate cancer: Intention to use, expected effects, performance, and concerns of urologists	3
Weekly versus 2-weekly versus 3-weekly docetaxel to treat metastatic castration-resistant prostate cancer	3
Single-dose vs prolonged antibiotic prophylaxis of fosfomycin for transrectal prostate biopsy: a single-center prospective, randomized, controlled trial	3
Pain relieving effect of music on patients during transrectal ultrasonography: A pilot study	3
Surgical management of post prostatectomy incontinence	3
Do bony pelvis parameters affect perioperative outcomes in open radical prostatectomy?	3